S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
Log in
CVE:LBL

Lattice Biologics Ltd. (LBL.V) Stock Forecast, Price & News

C$0.12
+0.03 (+25.00 %)
(As of 01/19/2021 03:59 PM ET)
Add
Compare
Today's Range
C$0.09
Now: C$0.13
C$0.13
50-Day Range
C$0.00
MA: C$0.05
C$0.10
52-Week Range
C$0.02
Now: C$0.13
C$0.21
Volume2.37 million shs
Average Volume2.12 million shs
Market CapitalizationC$16.03 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. The company offers AmnioBoost, an allograft amniotic fluid visco supplement for the treatment of joint pain associated with osteoarthritis, as well as traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.

MarketRank

Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-2356701
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$2.19 million
Book ValueC($0.06) per share

Profitability

Miscellaneous

Market CapC$16.03 million
Next Earnings Date2/26/2021 (Estimated)
OptionableNot Optionable
C$0.12
+0.03 (+25.00 %)
(As of 01/19/2021 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LBL News and Ratings via Email

Sign-up to receive the latest news and ratings for LBL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lattice Biologics Ltd. (LBL.V) (CVE:LBL) Frequently Asked Questions

How has Lattice Biologics Ltd. (LBL.V)'s stock price been impacted by COVID-19?

Lattice Biologics Ltd. (LBL.V)'s stock was trading at C$0.03 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, LBL stock has increased by 316.7% and is now trading at C$0.13.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Lattice Biologics Ltd. (LBL.V)?

Wall Street analysts have given Lattice Biologics Ltd. (LBL.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lattice Biologics Ltd. (LBL.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Lattice Biologics Ltd. (LBL.V)'s next earnings date?

Lattice Biologics Ltd. (LBL.V) is scheduled to release its next quarterly earnings announcement on Friday, February 26th 2021.
View our earnings forecast for Lattice Biologics Ltd. (LBL.V)
.

Who are some of Lattice Biologics Ltd. (LBL.V)'s key competitors?

What other stocks do shareholders of Lattice Biologics Ltd. (LBL.V) own?

Who are Lattice Biologics Ltd. (LBL.V)'s key executives?

Lattice Biologics Ltd. (LBL.V)'s management team includes the following people:
  • Mr. Guy S. Cook, Chairman, Pres & CEO (Age 55, Pay $360k)
  • Ms. Donna Medina, Interim Chief Financial Officer

What is Lattice Biologics Ltd. (LBL.V)'s stock symbol?

Lattice Biologics Ltd. (LBL.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LBL."

How do I buy shares of Lattice Biologics Ltd. (LBL.V)?

Shares of LBL and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Lattice Biologics Ltd. (LBL.V)'s stock price today?

One share of LBL stock can currently be purchased for approximately C$0.13.

How big of a company is Lattice Biologics Ltd. (LBL.V)?

Lattice Biologics Ltd. (LBL.V) has a market capitalization of C$16.03 million and generates C$2.19 million in revenue each year.

What is Lattice Biologics Ltd. (LBL.V)'s official website?

The official website for Lattice Biologics Ltd. (LBL.V) is www.latticebiologics.com.

How can I contact Lattice Biologics Ltd. (LBL.V)?

Lattice Biologics Ltd. (LBL.V)'s mailing address is 16701 N 90th St Ste 101, SCOTTSDALE, AZ 85260-1012, United States. The company can be reached via phone at +1-604-2356701.

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.